Anti-Cancer Activity of a 5-Aminopyrazole Derivative Lead Compound (BC-7) and Potential Synergistic Cytotoxicity with Cisplatin against Human Cervical Cancer Cells

Synthesis of Novel Pyrazole Derivatives and Their Tumor Cell Growth Inhibitory Activity

(2019) Ying-Jie Cui et al.   MOLECULES

In Vitro Anti-proliferative Activity and Mechanism of Action of Anemone nemorosa

(2019) Bresler Swanepoel et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells

(2019) Zuzana Mrkvová et al.   MOLECULES

Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review

(2018) Khalid Karrouchi et al.   MOLECULES

Cardamonin enhances the anti-proliferative effect of cisplatin on ovarian cancer

(2018) Peiguang Niu et al.   Oncology Letters

G2/M-Phase Checkpoint Adaptation and Micronuclei Formation as Mechanisms That Contribute to Genomic Instability in Human Cells

(2017) Danî Kalsbeek et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Significance of Various Experimental Models and Assay Techniques in Cancer Diagnosis

(2017) Raksha Ghanghoria et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Transcriptome Analysis of Gene Expression Provides New Insights into the Effect of Mild Therapeutic Hypothermia on Primary Human Cortical Astrocytes Cultured under Hypoxia

(2017) Mootaz M. Salman et al.   Frontiers in Cellular Neuroscience

Combination therapy in combating cancer

(2017) Reza Bayat Mokhtari et al.   Oncotarget

Cancer cells that survive checkpoint adaptation contain micronuclei that harbor damaged DNA

(2016) Cody W. Lewis et al.   CELL CYCLE

Ultrasound-assisted synthesis and anticancer evaluation of new pyrazole derivatives as cell cycle inhibitors

(2015) George Mihai Nitulescu et al.   Arabian Journal of Chemistry

MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1

(2015) Shaohua Xu et al.   Oncotarget

Hydrogen peroxide/ATR-Chk2 activation mediates p53 protein stabilization and anti-cancer activity of cheliensisin A in human cancer cells

(2015) Jingjie Zhang et al.   Oncotarget

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells

(2014) Juan Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo

(2012) Chia-Jung Li et al.   CANCER LETTERS

Recent advances in apoptosis, mitochondria and drug resistance in cancer cells

(2011) Inthrani R. Indran et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Molecular Pathways for Cancer Chemoprevention by Dietary Phytochemicals

(2011) Aaron C. Tan et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Generation of Reactive Oxygen Species during Apoptosis Induced by DNA-Damaging Agents and/or Histone Deacetylase Inhibitors

(2011) Barbora Brodská et al.   Oxidative Medicine and Cellular Longevity

Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

(2011) Ana-Maria Florea et al.   Cancers

Reactive oxygen species, cellular redox systems, and apoptosis

(2010) Magdalena L. Circu et al.   FREE RADICAL BIOLOGY AND MEDICINE

Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells

(2010) Barbie Taylor-Harding et al.   GYNECOLOGIC ONCOLOGY

Survival of European children and young adults with cancer diagnosed 1995–2002

(2009) Gemma Gatta et al.   EUROPEAN JOURNAL OF CANCER

Chemotherapy for recurrent cervical cancer

(2008) D. Pectasides et al.   CANCER TREATMENT REVIEWS